E-Library - Information At Your Fingertips: Printer Friendly 21 of 48 http://elibrary.judiciary.gov.ph/thebookshelf/showdocsfriendly/1/63027 [26] ZAMECO II Board of Directors v. Castillejos Consumers Ass'n. Inc. (CASCONA), et al., 600 Phil. 365, (2009). [27] SEC v. Court of Appeals, 316 Phil. 903 (1995). [28] G.R. No. 205728, January 21, 2015, 747 SCRA 1. ("This case pertains to acts of COMELEC in the implementation of its regulatory powers. When it issued the notice and letter, the COMELEC was allegedly enforcing election laws.") [29] Republic of the Phils. v. Sandiganbayan, 461 Phil. 598 (2003). [30] Ynot v. Intermediate Appellate Court, No. L-74457, March 20, 1987, 148 SCRA 659. [31] Tatad v. Sandiganbayan, 242 Phil. 563, 575-576 (1988). [32] Rollo (G.R. No. 217872), p. 18. [33] Decision, p. 15. [34] Rollo, pp. 418-419. [35] Section 7.04. FDA Certification of Family Planning Supplies. The FDA must certify that a family planning drug or device is not an abortifacient in dosages of its approved indication (for drugs) or intended use (for devices) prior to its inclusion in the EDL. The FDA shall observe the following guidelines in the determination of whether or not a drug or device is an abortifacient: a) As define in Section 3.01 (a) of these Rules, a drug or device is deemed to be an abortifacient if it is proven to primarily induce abortion or the destruction of a fetus inside the mother's womb or the prevention of the fertilized ovum to reach and be implanted in the mother's womb; b) The following mechanisms do not constitute abortion: the prevention of ovulation; the direct action on sperm cells prior to fertilization; the thickening of cervical mucus; and any mechanism acting exclusively prior to the fertilization of the egg by the sperm; c) In making its determination, the FDA shall use the best evidence available, including but not limited to: meta-analyses, systematic reviews, national clinical practice guidelines where available, and recommendations of international medical organizations; d) In the presence of conflicting evidence, the more recent, better-designed, and larger studies shall be preferred, and the conclusions found therein shall be used to 4/21/2020, 9:19 AM